Israeli, Italian firms push ahead with plasma-based COVID-19 treatmentThe two companies hope to gain approval from the US Food and Drug Administration (FDA), as well as with other regulatory bodies across the world.Plasma bags are pictured at the Interregional Transfusion CRS in Bern(photo credit: DENIS BALIBOUSE/REUTERS)
